Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Atypical Teratoid/Rhabdoid Tumor
- Central Nervous System Tumor
- Choroid Plexus Carcinoma
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma
- Ependymoma
- Germ Cell Tumor
- Glioma
- Medulloblastoma, Childhood
- Pineoblastoma, Childhood
- Primitive Neuroectodermal Tumor
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 1 years and 26 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04185038
- Collaborators
- Not Provided
- Investigators
- Study Chair: Nick Vitanza, MD Seattle Children's Hospital